| Current Price | $3.85 | Mkt Cap | $883.5M |
|---|---|---|---|
| Open | $3.83 | P/E Ratio | 0.00 |
| Prev. Close | $3.79 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $3.75 - $3.86 | Volume | 1,195,556 |
| 52-Wk Range | $2.50 - $6.79 | Avg. Daily Vol. | 4,269,718 |
A biotechnology company, developing technologies and products to treat cancers and infectious diseases, based on immunological approaches.
| Current Price | $3.85 | Mkt Cap | $883.5M |
|---|---|---|---|
| Open | $3.83 | P/E Ratio | 0.00 |
| Prev. Close | $3.79 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $3.75 - $3.86 | Volume | 1,195,556 |
| 52-Wk Range | $2.50 - $6.79 | Avg. Daily Vol. | 4,269,718 |
The best Bull and Bear pitches based on recency and number of recommendations.
I'm an Agenus skeptic but I think there's a good chance of a rebound ahead of topline data from the phase II trial of HerpV therapeutic herpes simplex 2 vaccine expected in Q4 2013. A good bellwether for the trial results will be if Agenus decides to… More
Read the most recent pitches from players about AGEN.
Recs
StevesStox
(< 20)
Submitted: 7/15/2021 6:01:16 AM :
Start Price:
$5.46
NASDAQ:AGEN Score:
-35.10
AGEN-1181 is the real deal.
Recs
PM7
(< 20)
Submitted: 1/24/2021 12:14:01 AM :
Start Price:
$3.47
NASDAQ:AGEN Score:
-8.96
Significant number of drugs under final stages of phase 2 and 3 trials and 2 of them likely to get FDA approval and both on FDA fast track.
Recs
rocknrook
(58.77)
Submitted: 6/27/2017 7:53:50 AM :
Start Price:
$4.01
NASDAQ:AGEN Score:
-92.63
Assuming effective test results. I like that there is significant interest from big players in partnering.
Find the members with the highest scoring picks in AGEN.
svande8952 (87.89) Score: +466.09
The Score Leader is the player with the highest score across all their picks in AGEN.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| svande8952 | 87.89 | 6/16/2009 |
|
5Y | $12.24 | -68.87% | +397.22% | +466.09 | 1 Comment | |
| 1or5stars | 99.26 | 6/8/2009 |
|
3W | $13.68 | -72.15% | +391.04% | +463.19 | 0 Comment | |
| TWreckz | 99.23 | 6/5/2009 |
|
5Y | $15.90 | -76.04% | +382.43% | +458.47 | 0 Comment | |
| rcbaldwinjr | 78.73 | 8/5/2009 |
|
3W | $13.85 | -72.50% | +359.43% | +431.93 | 0 Comment | |
| rhinomaj | < 20 | 8/4/2009 |
|
3M | $14.34 | -73.43% | +356.54% | +429.97 | 0 Comment | |
| epc53 | 26.33 | 8/7/2009 |
|
5Y | $13.26 | -71.27% | +353.95% | +425.22 | 0 Comment | |
| BadCopNoDonuts | < 20 | 7/28/2010 |
|
5Y | $5.64 | -32.45% | +309.67% | +342.11 | 0 Comment | |
| JackOffBadApples | 65.30 | 9/12/2008 |
|
3W | $10.02 | -61.98% | +278.51% | +340.48 | 0 Comment | |
| chop3399 | < 20 | 3/13/2008 |
|
5Y | $13.44 | -71.65% | +266.70% | +338.36 | 0 Comment | |
| DayTr8der88 | < 20 | 9/22/2008 |
|
NS | $9.90 | -61.52% | +275.54% | +337.05 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
